01 July 1999
Susceptibility of Candida strains towards antimycotics independent of the site of their isolation
Elżbieta Krajewska-Kułak, Wiaczesław Niczyporuk, Cecylia Łukaszuk, Waldemar Winter, Wiesław ZłotkowskiMed Sci Monit 1999; 5(4): BR640-646 :: ID: 503463
Abstract
We determined the in vitro susceptibility towards antimycotics of 928 yeast-like fungi Candida strains independent of the site of their isolation by means of the disk-diffusion test. There were 928 strains isolated from the mouth, vagina, urethra, skin and patient secretions and excretions. We evaluated the susceptibility of Candida towards antimycotics on the YNB medium by means of the disk-diffusion test produced by Dom Handlowy Nauki Sp. z o.o. PAN in Cracow. Studies were performed according to producer notes. The most active antimycotics against all yeast-like fungi strains independent of the site of their isolation included 5-fluorocytosine (95.90% of sensitive isolates), pimaricine (25.65% of sensitive isolates) and fluconazole (27.59%). Amongst imidazole derivatives the most active included clotrimazole (74.78% of isolates were sensitive) and tioconazole (65.63% of isolates were sensitive). Of all yeast-like fungi isolates 30.50% demonstrated in vitro resistance towards ketoconazole and 25.54% towards miconazole. Out of Candida albicans isolates 2.59% were resistant towards 5-fluorocytosine, and 53.88% showed resistance towards fluconazole, respectively. Total resistance towards two or more antimycotics independent of the site of their isolation amounted to 40.10%. The highest percentage of resistant strains towards 2 or more antimycotics was noted in 66% of urethra isolates, and the lowest percentage of resistant strains was found in 32.60% of mouth isolates. We noted significant isolate differences towards antifungal agents independent of the species and their site of isolation. In vitro studies demonstrated a great percentage of strains resistant towards imidazoles.
Keywords: disk-diffusion test, in vitro tests, candida strains
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952